Literature DB >> 34199804

Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (PERSPECTIVE I&I).

Jennifer D Brooks1, Hermann H Nabi2,3,4, Irene L Andrulis5, Antonis C Antoniou6, Jocelyne Chiquette2,7, Philippe Després8, Peter Devilee9, Michel Dorval2,4,10,11, Arnaud Droit12, Douglas F Easton6, Andrea Eisen13, Laurence Eloy14, Samantha Fienberg15, David Goldgar16, Eric Hahnen17, Yann Joly18, Bartha Maria Knoppers18, Aisha Lofters19, Jean-Yves Masson2,4, Nicole Mittmann13,20, Jean-Sébastien Paquette7, Nora Pashayan21, Rita Schmutzler17, Tracy Stockley22,23, Sean V Tavtigian16, Meghan J Walker1,15, Michael Wolfson24, Anna Maria Chiarelli1,15, Jacques Simard2,12.   

Abstract

Early detection of breast cancer through screening reduces breast cancer mortality. The benefits of screening must also be considered within the context of potential harms (e.g., false positives, overdiagnosis). Furthermore, while breast cancer risk is highly variable within the population, most screening programs use age to determine eligibility. A risk-based approach is expected to improve the benefit-harm ratio of breast cancer screening programs. The PERSPECTIVE I&I (Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation) project seeks to improve personalized risk assessment to allow for a cost-effective, population-based approach to risk-based screening and determine best practices for implementation in Canada. This commentary describes the four inter-related activities that comprise the PERSPECTIVE I&I project. 1: Identification and validation of novel moderate to high-risk susceptibility genes. 2: Improvement, validation, and adaptation of a risk prediction web-tool for the Canadian context. 3: Development and piloting of a socio-ethical framework to support implementation of risk-based breast cancer screening. 4: Economic analysis to optimize the implementation of risk-based screening. Risk-based screening and prevention is expected to benefit all women, empowering them to work with their healthcare provider to make informed decisions about screening and prevention.

Entities:  

Keywords:  breast cancer; risk prediction; risk stratification; screening

Year:  2021        PMID: 34199804     DOI: 10.3390/jpm11060511

Source DB:  PubMed          Journal:  J Pers Med        ISSN: 2075-4426


  9 in total

1.  Considerations of biomarker application for cancer continuum in the era of precision medicine.

Authors:  Rayjean J Hung; Elham Khodayari Moez; Shana J Kim; Sanjeev Budhathoki; Jennifer D Brooks
Journal:  Curr Epidemiol Rep       Date:  2022-07-09

2.  Body mass index, breast density, and the risk of breast cancer development in relation to the menopausal status; results from a population-based screening program in a native African-Arab country.

Authors:  Rasha M Kamal; Salma Mostafa; Dorria Salem; Ahmed M ElHatw; Sherif M Mokhtar; Rasha Wessam; Sherihan Fakhry
Journal:  Acta Radiol Open       Date:  2022-06-30

3.  Polygenic risk scores for prediction of breast cancer risk in Asian populations.

Authors:  Weang-Kee Ho; Mei-Chee Tai; Joe Dennis; Xiang Shu; Jingmei Li; Peh Joo Ho; Iona Y Millwood; Kuang Lin; Yon-Ho Jee; Su-Hyun Lee; Nasim Mavaddat; Manjeet K Bolla; Qin Wang; Kyriaki Michailidou; Jirong Long; Eldarina Azfar Wijaya; Tiara Hassan; Kartini Rahmat; Veronique Kiak Mien Tan; Benita Kiat Tee Tan; Su Ming Tan; Ern Yu Tan; Swee Ho Lim; Yu-Tang Gao; Ying Zheng; Daehee Kang; Ji-Yeob Choi; Wonshik Han; Han-Byoel Lee; Michiki Kubo; Yukinori Okada; Shinichi Namba; Sue K Park; Sung-Won Kim; Chen-Yang Shen; Pei-Ei Wu; Boyoung Park; Kenneth R Muir; Artitaya Lophatananon; Anna H Wu; Chiu-Chen Tseng; Keitaro Matsuo; Hidemi Ito; Ava Kwong; Tsun L Chan; Esther M John; Allison W Kurian; Motoki Iwasaki; Taiki Yamaji; Sun-Seog Kweon; Kristan J Aronson; Rachel A Murphy; Woon-Puay Koh; Chiea-Chuen Khor; Jian-Min Yuan; Rajkumar Dorajoo; Robin G Walters; Zhengming Chen; Liming Li; Jun Lv; Keum-Ji Jung; Peter Kraft; Paul D B Pharoah; Alison M Dunning; Jacques Simard; Xiao-Ou Shu; Cheng-Har Yip; Nur Aishah Mohd Taib; Antonis C Antoniou; Wei Zheng; Mikael Hartman; Douglas F Easton; Soo-Hwang Teo
Journal:  Genet Med       Date:  2021-12-15       Impact factor: 8.864

4.  Women's health behaviour change after receiving breast cancer risk estimates with tailored screening and prevention recommendations.

Authors:  Linda Rainey; Daniëlle van der Waal; Louise S Donnelly; Jake Southworth; David P French; D Gareth Evans; Mireille J M Broeders
Journal:  BMC Cancer       Date:  2022-01-16       Impact factor: 4.430

5.  Study protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the "My Personal Breast Screening" (MyPeBS) randomised clinical trial.

Authors:  Alexandra Roux; Rachel Cholerton; Jonathan Sicsic; Nora Moumjid; David P French; Paolo Giorgi Rossi; Corinne Balleyguier; Michal Guindy; Fiona J Gilbert; Jean-Benoit Burrion; Xavier Castells; David Ritchie; Debbie Keatley; Camille Baron; Suzette Delaloge; Sandrine de Montgolfier
Journal:  BMC Cancer       Date:  2022-05-06       Impact factor: 4.638

6.  Overdetection of Breast Cancer.

Authors:  Martin J Yaffe; James G Mainprize
Journal:  Curr Oncol       Date:  2022-05-30       Impact factor: 3.109

7.  Feasibility and Acceptability of Personalized Breast Cancer Screening (DECIDO Study): A Single-Arm Proof-of-Concept Trial.

Authors:  Celmira Laza-Vásquez; Montserrat Martínez-Alonso; Carles Forné-Izquierdo; Jordi Vilaplana-Mayoral; Inés Cruz-Esteve; Isabel Sánchez-López; Mercè Reñé-Reñé; Cristina Cazorla-Sánchez; Marta Hernández-Andreu; Gisela Galindo-Ortego; Montserrat Llorens-Gabandé; Anna Pons-Rodríguez; Montserrat Rué
Journal:  Int J Environ Res Public Health       Date:  2022-08-21       Impact factor: 4.614

8.  Personalized Approaches for the Prevention and Treatment of Breast Cancer.

Authors:  Hermann Nabi
Journal:  J Pers Med       Date:  2022-07-23

9.  Implementing Risk-Stratified Breast Screening in England: An Agenda Setting Meeting.

Authors:  Lorna McWilliams; D Gareth Evans; Katherine Payne; Fiona Harrison; Anthony Howell; Sacha J Howell; David P French
Journal:  Cancers (Basel)       Date:  2022-09-24       Impact factor: 6.575

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.